Does EVOLOCUMAB Cause Infection? 136 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Infection have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
136
Reports of Infection with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
7
Deaths
65
Hospitalizations
How Dangerous Is Infection From EVOLOCUMAB?
Of the 136 reports, 7 (5.1%) resulted in death, 65 (47.8%) required hospitalization.
Is Infection Listed in the Official Label?
Yes, Infection is listed as a known adverse reaction in the official FDA drug label for EVOLOCUMAB.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Infection?
ADALIMUMAB (11,552)
METHOTREXATE (10,406)
ETANERCEPT (10,379)
RITUXIMAB (9,575)
ABATACEPT (7,821)
TOCILIZUMAB (7,349)
PREDNISONE (6,334)
TOFACITINIB (6,332)
INFLIXIMAB (6,122)
CERTOLIZUMAB PEGOL (5,954)
Which EVOLOCUMAB Alternatives Have Lower Infection Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE